Evaluation of Choroidal Thickness during Pregnancy and Postpartum: A Longitudinal Study



   Table of Contents   ORIGINAL ARTICLE Year : 2022  |  Volume : 34  |  Issue : 3  |  Page : 312-317

Evaluation of Choroidal Thickness during Pregnancy and Postpartum: A Longitudinal Study

Yousef Alizadeh1, Zahra Moravvej2, Reza Soltani-Moghadam1, Maryam Dourandeesh1, Mitra Akbari1, Ebrahim Azaripour1, Abdolreza Medghalchi1, Ziba Zahiri Sorouri3, Zahra Motaghinia4
1 Department of Eye, Eye Research Center, Amiralmomenin Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
2 Department of Eye, Eye Research Center, Amiralmomenin Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht; Department of Ophthalmology, Hakim Hospital, Neyshabour University of Medical Sciences, Neyshabour, Iran
3 Department of Obstetrics and Gynecology, Reproductive Health Research Center, Alzahra Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
4 Department of Ophthalmology, School of Medicine, Arak University of Medical Sciences, Arak, Iran

Date of Submission05-Feb-2022Date of Decision22-May-2022Date of Acceptance12-Jun-2022Date of Web Publication30-Nov-2022

Correspondence Address:
Zahra Moravvej
Department of Ophthalmology, School of Medicine, Arak University of Medical Sciences, Arak
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/joco.joco_42_22

Rights and Permissions


Purpose: To assess the longitudinal changes of choroidal thickness using enhanced depth imaging optical coherence tomography (EDI-OCT) during pregnancy and postpartum.
Methods: The study included 23 eyes of 23 healthy pregnant women and 23 eyes of 23 healthy nonpregnant women. Choroidal thickness was measured manually with EDI-OCT at seven locations: The fovea, 500, 1000, and 1500 μm temporal (T) from the fovea and 500, 1000, and 1500 μm nasal (N) from the fovea. Measurements were obtained at each pregnancy trimester and 6 weeks postpartum and in the follicular phase of the menstrual cycle for the control group.
Results: The mean subfoveal choroidal thickness was 410.2 ± 82.4 μm, 434.8 ± 79.6 μm, 433.5 ± 80.3 μm, and 395.0 ± 71.1 μm in the first, second, and third trimesters and 6 weeks postpartum, respectively. In all seven measured locations, statistically significant changes were noted during pregnancy and postpartum in the choroidal thickness (P < 0.001). Choroidal thickness increased from the first trimester to the second and third trimester, after which it decreased at postpartum. Choroidal thickness was greater in the pregnant group during pregnancy and postpartum compared to the control group (P < 0.001).
Conclusions: This study indicated significant change in choroidal thickness at seven locations measured with EDI-OCT throughout pregnancy and 6 weeks after delivery. We showed that 6 weeks after delivery, choroidal thickness remains significantly higher than nonpregnant subjects.

Keywords: Choroid, Optical coherence tomography, Postpartum, Pregnancy, Trimester


How to cite this article:
Alizadeh Y, Moravvej Z, Soltani-Moghadam R, Dourandeesh M, Akbari M, Azaripour E, Medghalchi A, Sorouri ZZ, Motaghinia Z. Evaluation of Choroidal Thickness during Pregnancy and Postpartum: A Longitudinal Study. J Curr Ophthalmol 2022;34:312-7
How to cite this URL:
Alizadeh Y, Moravvej Z, Soltani-Moghadam R, Dourandeesh M, Akbari M, Azaripour E, Medghalchi A, Sorouri ZZ, Motaghinia Z. Evaluation of Choroidal Thickness during Pregnancy and Postpartum: A Longitudinal Study. J Curr Ophthalmol [serial online] 2022 [cited 2022 Dec 2];34:312-7. Available from: http://www.jcurrophthalmol.org/text.asp?2022/34/3/312/362463   Introduction Top

Pregnancy is a period associated with many physiologic changes throughout the body.[1] The majority of these changes occur in the hormonal, hematologic, and cardiovascular systems. As it is well understood, the blood volume is increased during pregnancy, reaching 40%–45% higher than prepregnancy volumes by the 32–34 weeks of gestation.[2] Furthermore, an increase in the cardiac output and reduction of peripheral vascular resistance provide a suitable situation for fetus development.

The impact of these hormonal and hemodynamic alterations on the ocular structure has been studied in the literature. Changes in central corneal thickness, corneal curvature, and intraocular pressure (IOP) have been well documented.[3],[4] Since the choroid has the highest blood flow per unit weight in the body and supplies much of the nutritional needs of the retina, choroidal changes may lead to various ophthalmic conditions.[5],[6] Investigating choroidal changes during pregnancy offers insight to ocular pathologies encountered in this period such as central serous chorioretinopathy (CSC) and eclampsia-associated retinopathy.[7],[8] The extent of these choroidal changes and its reversibility after pregnancy is of great clinical significance.

Optical coherence tomography (OCT) is an essential device for diagnosing retinal and choroidal pathologies and evaluating treatment. New-generation OCT devices perform scans much faster, hence providing higher resolution imaging with extensive detail. Studies have shown the great reproducibility and repeatability of spectral-domain OCT (SD-OCT) in retinal and choroidal thickness assessment.[9],[10],[11] The enhanced depth imaging (EDI) technique of SD-OCT is a precise and noninvasive method, ideal for documenting the choroidal morphology.[12],[13] The choroidal thickness is a useful parameter in indicating physiologic and pathologic ocular changes as it is affected by the blood flow and ocular perfusion pressure (OPP). Various studies with controversial results have reported choroidal thickness in pregnancy and pregnancy-associated states.[3],[14],[15],[16] A review of current literature indicated inadequate longitudinal research which determines choroidal thickness during pregnancy and postpartum. Therefore, the purpose of this study was to longitudinally monitor the changes in choroidal thickness during each trimester and postpartum and also compare the results with a control group.

  Methods Top

This prospective, longitudinal study included 23 eyes of 23 healthy pregnant women and 23 eyes of 23 healthy nonpregnant women. To ensure unbiased results, only one eye (right eye) was included for each study participant. Participants from both groups were recruited from the Gynecology and Obstetrics clinic at the same university hospital between January and August 2018. All participants provided written informed consent, and the purpose of the research was fully explained. The research protocol was approved by the local ethics committee (IR.GUMS.REC.1395.282) and adhered to the Declaration of Helsinki principles.

The inclusion criteria for the study group were healthy pregnant women in the first trimester, who attended prenatal care and completed pregnancy without any complications (including gestational diabetes, preeclampsia, or eclampsia). All the pregnancies were singleton and all participant were primigravid with no history of abortion. The control group consisted of healthy nulligravid women with regular menstrual cycles. All participants were between 18 and 40 years old and had refractive errors less than ± 1.0 diopters with a best-corrected visual acuity (BCVA) of ≥20/20 (Snellen chart), and IOP below 21 mmHg at the time of enrollment. Subjects with a history of anemia, diabetes, hypertension, polycystic ovarian syndrome, thyroid dysfunction, collagen vascular, renal, or cardiovascular diseases and smoking and those with any ocular pathology including any previous ocular intervention were excluded from the study.

Demographic and previous medical history of participants was obtained. A complete ophthalmic examination was performed, including refraction (Topcon KR-8000 autorefractor) and visual acuity testing, slit-lamp biomicroscopy, IOP measurement by Goldmann applanation tonometry, and dilated fundus examination. Axial length measurement was performed using an optical biometer (Lenstar 900, Haag-Streit AG, Switzerland). Data regarding patients systolic and diastolic blood pressure (BP), anthropometric data, and fasting blood sugar, blood urea nitrogen, creatinine and ferritin were also obtained. OPP was calculated based on the following formula: Mean BP-IOP.

For the pregnant group, choroidal thickness was measured at the first trimester (at 6–12 GA weeks), second trimester (at 16–22 GA weeks), and third trimester (at 28–34 GA weeks), and 6 weeks postpartum and for the control group in the follicular phase of the menstrual cycle. Participants were asked to avoid any caffeine containing diet, such as coffee, tea, and chocolate for 24 h before image acquisition. Measurements were acquired in the morning between 9 and 11 A.M. to avoid diurnal variations and after 15 min of rest in the sitting position. Choroidal thickness was measured using SD-OCT with the EDI technique (Spectralis; Heidelberg Engineering, Heidelberg, Germany). The macular region was scanned using a horizontal 1-line raster scan (30° × 5°) centered on the fovea, generated from 7 B-scans with 100 frames averaged per scan. The choroidal thickness was measured as the vertical distance from Bruch's membrane to the choroid-sclera interface (hyperreflective line of the inner surface of the sclera) using the manual caliper in the Heidelberg software. All OCT imaging were separately assessed by two ophthalmologists.

Choroidal thickness measurements were obtained at seven locations: At the fovea, 500, 1000, and 1500 μm temporal (T) from the fovea and 500, 1000, and 1500 μm nasal (N) from the fovea.

Statistical analyses were performed using the SPSS Statistics version 21 (IBM-SPSS, Chicago, IL, USA). Variables are presented as mean ± standard deviation were appropriate. To compare variables between groups, Student's t-test and Mann–Whitney test was used for normally and nonnormally distributed data, respectively. Changes in choroidal thickness were analyzed using Repeated Measures analysis of variance (ANOVA). Furthermore, multiple comparisons with Bonferroni adjustment were performed. The post hoc Dunnett test was performed for comparison between each time point in the pregnancy group and the control group. Subjects with missing data were omitted from the analysis. A linear regression analysis with choroidal thickness as a dependent parameter and ocular and general parameters as independent parameters was performed. All P values were 2-sided, and a P < 0.05 was considered statistically significant.

  Results Top

The study enrolled 23 eyes of pregnant women and 23 eyes of age-matched women for the control group. Two participants in the pregnant group did not complete follow-up for the third trimester and postpartum imaging, and thus, analyzed as missing data. One patient who had premature delivery was excluded from the study, and another healthy pregnant woman was recruited for replacement. All other participants in the pregnant group had normal vaginal delivery.

The mean age was 26.1 ± 3.6 years (range, 22–34) at the time of the first examination in the pregnant group and 26.7 ± 4.0 (range, 21–34) in the control group. IOP was within the normal range in both groups. The BCVA was 20/20 or better for all participants. Baseline clinical evaluations were not statistically different between the two groups, except for the body mass index (BMI), which was higher in the pregnant group. This difference in BMI was probably due to the weight gain which occurs in pregnancy. Hemoglobin was also in the normal range for all subjects of both groups, although significantly lower in the pregnant group. [Table 1] shows demographic and baseline clinical data in the two groups.

Table 1: Demographic and baseline clinical parameters in the pregnant and control groups

Click here to view

[Table 2] shows the mean choroidal thickness in the pregnancy and control group in each measured location. The mean subfoveal choroidal thickness was 410.2 ± 82.4 μm, 434.8 ± 79.6 μm, 433.5 ± 80.3 μm, and 395.0 ± 71.1 μm in the first, second, and third trimesters, and 6 weeks postpartum, respectively. The temporal choroid was thicker compared to the nasal choroid in all pregnancy time points and also the control group.

Table 2: Choroidal thickness in different locations in the pregnant group at study time-points and control group

Click here to view

Based on the repeated-measures ANOVA, there was statistically significant change during pregnancy and postpartum in the choroidal thickness in all seven locations [Table 2] and [Figure 1].

Figure 1: Subfoveal, temporal, and nasal choroidal thickness distribution in the pregnant group at different study time-points and the control group

Click here to view

We noted an increase in mean choroidal thickness from the first trimester to the second trimester, which was statistically significant only in the temporal 500 μm from fovea region [Table 3]. In the 3rd trimester, the thickness remained nearly the same as the 2nd trimester, with no significant difference in multiple comparison of 2nd and 3rd trimesters [Table 3]. The mean choroidal thickness decreased significantly after delivery. [Table 3] shows P values for multiple pairwise comparisons of mean choroidal thickness in pregnancy trimesters and postpartum.

Table 3: Multiple comparisons of choroidal thickness between pregnancy trimesters and postpartum

Click here to view

Choroidal thickness was greater in all 7 locations during pregnancy and postpartum compared to the control group (P < 0.001 for all time points). Mean subfoveal, nasal, and temporal (500–1500 μm from fovea) choroidal thickness is shown in box plots in the pregnant women and control groups [Figure 1].

Correlation between the choroidal thickness in different locations and baseline BMI, BP, OPP (the first trimester for pregnant group) was evaluated using Pearson's correlation. No significant correlation was found between the choroidal thickness and BP and OPP, whereas choroidal thickness in all seven locations was positively correlated with BMI [Table 4].

Table 4: Pearson's correlation coefficient for choroidal thickness and body mass index

Click here to view

  Discussion Top

Pregnancy-related hormonal, hemodynamic, and cardiovascular changes can affect the ocular structures.[17] The complex vascular structure of the choroid makes it vulnerable to pregnancy-related alterations, either the physiologic or pathologic events. Choroidal thickness changes can be expected due to the increased blood volume and water retention during pregnancy.[18],[19] Certain ocular conditions such as CSC, serous retinal detachment, and retinal vascular events have an increased prevalence during pregnancy.[20],[21]

There is no definite consensus on whether pregnancy can change choroidal structure and thickness and whether these changes are reversible. Previous studies have shown controversial results regarding choroidal thickness in pregnant women. Studies by Rothwell et al., Kara et al., Ataş et al.,[22] Sayin et al., and Acmaz et al. have shown increased choroidal thickness in the third trimester of pregnancy compared to controls,[14],[22],[23],[24],[25] whilst Takahashi et al., Benfica et al., Su et al., and Kim et al. found no significant difference between choroidal thickness of healthy pregnant women in the third trimester and the control group.[26],[27],[28],[29] A recent meta-analysis concluded that choroidal thickness is significantly higher in healthy pregnant patients over 24 weeks of GA compared to controls.[30]

The case-control and cross-sectional design of most of these previous studies has limited the achievement of definite results due to individual bias. The choroidal thickness is affected by various factors including age, sex, systemic or local diseases, diurnal variation, IOP, axial length, menstrual cycle, and pregnancy trimester.[31],[32],[33] In our study, we considered these confounding variables, and their effect was eliminated to a great extent. Other factors such as previous pregnancy were regarded in our study. We only included nulligravid women (no prior pregnancy) for the control group and primigravid women for our pregnant group, whereas most aforementioned studies have not accounted for this factor.[23],[24],[26],[34]

To date, very few studies have investigated choroid thickness changes in different trimesters and postpartum. Goktas et al. investigated choroidal thickness in the three trimesters but in different sets of pregnant patients at 3 points (subfoveal and 3 mm nasal and temporal to the fovea).[35] Their results showed significantly greater choroidal thickness in the 2nd trimester group in comparison with the 1st and 3rd trimester and control groups. They did not find any statistical difference between the 2nd and 3rd trimester groups and the control. Greene and Capkin also conducted a study with a similar design but used the average measurement of subfoveal, 500 μm nasal and temporal choroidal thickness.[15] The choroidal thickness was significantly lower in the 3rd trimester compared to the 1st and 2nd trimester and also compared to the control group. They did not find any statistical difference between the 1st and 2nd trimester groups and the control. In our study, on the other hand, we observed significantly thicker choroids in all three pregnancy trimesters compared to control. We also demonstrated increasing choroidal thickness from the first trimester into the second and third trimesters. The fact that Goktas et al. and Greene and Capkin included different patients for each trimester may have caused the dissimilar results.[15],[35] Moreover, as choroidal thickness is affected by the menstrual cycle, we measured the choroidal thickness of the control group in the follicular phase. This issue was not addressed in neither of the two mentioned studies.

Dadaci et al. compared choroidal thickness of pregnant women in the first trimester (6–8 GA weeks) with the third trimester (32–37 GA weeks).[36] Similar to our findings, they reported thicker choroids during pregnancy compared to control. However, choroidal thickness decreased significantly in the third trimester compared to the first trimester. As we noted in our study, the choroidal thickness in the 3rd trimester was similar to that of the 2nd trimester and greater than the 1st trimester. We believe different sampling time points in the 3rd trimester may have caused this disagreement, as our measurements were taken between 28 and 34 weeks GA, and theirs was between 32 and 37 GA weeks. Reasons for this finding may be that toward the end of pregnancy, blood flow is redistributed to vital organs and increase in adrenoreceptor activity leads to vasoconstriction.[37],[38]

It has been proposed that increased blood flow, enhanced arterial compliance, and decreased vascular resistance during pregnancy leads to an increase in choroidal thickness.[16] Furthermore, fluid retention in the choroidal layer may affect the thickness.[39] Kim et al., Benfica et al., and Sharudin et al. noted significantly greater choroidal thickness in patients with pre-eclampsia compared to the healthy pregnancy group.[27],[40],[41] This may suggest a correlation between choroidal thickness and OPP, rather than pregnancy itself. However, other studies in line with ours did not find a correlation between OPP and choroidal thickness.[23],[34],[35] This issue may highlight the influence of hormones, particularly estrogen, progesterone and cortisol, on choroidal thickness.[5],[33]

In the present longitudinal study, we also measured choroidal thickness after delivery. Previous studies on choroidal thickness before and after delivery have displayed conflicting results. Ulusoy et al. examined subfoveal choroidal thickness in third trimester (36 weeks GA) pregnant woman and prospectively 3 months after delivery.[34] They reported significant decrease in the thickness 3 months after delivery. In contrast Taradaj et al., which assessed choroidal thickness at 36 weeks GA and at 6th week after delivery, reported greater choroidal thickness at 6th week postpartum compared to 36 weeks GA.[42] In addition, they evaluated choroidal thickness changes depending on the mode of delivery and reported more noticeable changes in the cesarean section group compared to normal labor. Therefore, mode of delivery is presumed to affect the choroidal thickness postpartum. As mentioned, all our participants had normal vaginal delivery.

Takahashi et al. were the first to evaluate choroidal thickness from early pregnancy until after delivery in the same group of patients.[43] They measured the subfoveal choroidal thickness of 25 eyes of pregnant women in the 1st and 3rd trimesters, shortly after delivery, and 1 month postpartum. Their results indicated that the choroidal thickness increases in the first trimester and decreases in the third trimester and remains subsequently unchanged until the 1st month after delivery. In comparison to our study, in which we measured choroidal thickness in seven locations, Takahashi et al. only measured the subfoveal choroidal thickness. Moreover, their study did not include measurements at the 2nd trimester of pregnancy.[43]

In contrast to Takahashi et al.,[43] we showed that the choroidal thickness changed significantly during pregnancy and postpartum, with increased thickness until the 3rd trimester and subsequent reduction at 6 weeks postpartum in all seven measured locations. Takahashi et al. postpartum measurements were done at 4 weeks after delivery, this issue is of clinical relevance as the regression of pregnancy-related physiological changes takes place at 6–7 weeks postpartum.[1],[43] In our study, we also noted that postpartum choroidal thickness was still greater than the control. Takahashi et al., however, did not include a control group.

To the best of our knowledge, the present study is the first longitudinal design to evaluate the changes in choroidal thickness at several locations throughout pregnancy and postpartum and in comparison with nonpregnant healthy women. As there are considerable choroidal thickness variations between individuals, the longitudinal design of our study is of great value. To add to the strength of our study, we included a group of healthy nonpregnant women to compensate for the absent prepregnancy measurements. However, a study including prepregnancy choroidal measurements of the same group of patients would be the ideal and optimal design. Another advantage of our study was that all pregnant participants were primigravid. As it is debated whether previous pregnancy-related choroidal changes are reversible, this matter may act as a confounding factor.[44]

Our study also had some limitation. The first was the relatively small number of subjects as well as the drop-outs. However, previous studies also had a similar sample size, and drop-out is an inevitable part of longitudinal studies of this kind. Another limitation was the lack of patients' prepregnancy choroidal measurements and data. Further studies including prepregnancy choroidal thickness and longer postpartum follow-up measurements are needed to determine precise choroidal changes and reversal. Moreover, evaluating choroidal thickness in patients with pregnancy-related ocular complications can provide guidance for clinical practice.

In conclusion, our study showed significant change in choroidal thickness at seven locations measured with EDI OCT throughout pregnancy and 6 weeks after delivery. We showed that 6 weeks after delivery, choroidal thickness remains significantly higher than nonpregnant subjects.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 

  References Top
1.Ouzounian JG, Elkayam U. Physiologic changes during normal pregnancy and delivery. Cardiol Clin 2012;30:317-29.  Back to cited text no. 1
    2.Pritchard JA. Changes in the blood volume during pregnancy and delivery. Anesthesiology 1965;26:393-9.  Back to cited text no. 2
    3.Ataş M, Duru N, Ulusoy DM, Altınkaynak H, Duru Z, Açmaz G, et al. Evaluation of anterior segment parameters during and after pregnancy. Cont Lens Anterior Eye 2014;37:447-50.  Back to cited text no. 3
    4.Mackensen F, Paulus WE, Max R, Ness T. Ocular changes during pregnancy. Dtsch Arztebl Int 2014;111:567-75.  Back to cited text no. 4
    5.Sunness JS. The pregnant woman's eye. Surv Ophthalmol 1988;32:219-38.  Back to cited text no. 5
    6.Mrejen S, Spaide RF. Optical coherence tomography: Imaging of the choroid and beyond. Surv Ophthalmol 2013;58:387-429.  Back to cited text no. 6
    7.Razeghinejad MR, Tania Tai TY, Fudemberg SJ, Katz LJ. Pregnancy and glaucoma. Surv Ophthalmol 2011;56:324-35.  Back to cited text no. 7
    8.Rezai S, LoBue S, LoBue T, Giovane R, Carney M, Henderson C. Ophthalmic complications and ocular changes in pregnancy – A review. Obstet Gynecol Int J 2016;4:00093.  Back to cited text no. 8
    9.Tepelus TC, Hariri AH, Balasubramanian S, Sadda SR. Reproducibility of macular thickness measurements in eyes affected by dry age-related macular degeneration from two different SD-OCT instruments. Ophthalmic Surg Lasers Imaging Retina 2018;49:410-5.  Back to cited text no. 9
    10.Alizadeh Y, Panjtanpanah MR, Mohammadi MJ, Behboudi H, Kazemnezhad Leili E. Reproducibility of optical coherence tomography retinal nerve fiber layer thickness measurements before and after pupil dilation. J Ophthalmic Vis Res 2014;9:38-43.  Back to cited text no. 10
  [Full text]  11.Soltani-Moghadam R, Alizadeh Y, Kazemnezhad Leili E, Absari Haghighi M. Reproducibility of peripapillary retinal nerve fiber layer thickness measurements with cirrus HD-OCT in glaucomatous eyes. Int J Ophthalmol 2015;8:113-7.  Back to cited text no. 11
    12.Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 2008;146:496-500.  Back to cited text no. 12
    13.Yamashita T, Yamashita T, Shirasawa M, Arimura N, Terasaki H, Sakamoto T. Repeatability and reproducibility of subfoveal choroidal thickness in normal eyes of Japanese using different SD-OCT devices. Invest Ophthalmol Vis Sci 2012;53:1102-7.  Back to cited text no. 13
    14.Acmaz G, Atas M, Gulhan A, Acmaz B, Atas F, Aksoy H, et al. Assessment of macular peripapillary nerve fiber layer and choroidal thickness changes in pregnant women with gestational diabetes mellitus, healthy pregnant women, and healthy non-pregnant women. Med Sci Monit 2015;21:1759-64.  Back to cited text no. 14
    15.Greene B, Capkin M. Evaluation of choroid thickness and ocular perfusion pressure in healthy nonpregnant women and healthy pregnant women during first, second and third trimesters. Optom Open Access 2018;3:1.  Back to cited text no. 15
    16.Zhang J, Wang H, Yu Q, Tong Q, Lu Q. Enhanced depth imaging optical coherence tomography: A new way measuring choroidal thickness in pregnant women. J Ophthalmol 2017;2017:8296574.  Back to cited text no. 16
    17.Centofanti M, Migliardi R, Bonini S, Manni G, Bucci MG, Pesavento CB, et al. Pulsatile ocular blood flow during pregnancy. Eur J Ophthalmol 2002;12:276-80.  Back to cited text no. 17
    18.Kim SW, Oh J, Kwon SS, Yoo J, Huh K. Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy. Retina 2011;31:1904-11.  Back to cited text no. 18
    19.Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res 2010;29:144-68.  Back to cited text no. 19
    20.Neudorfer M, Spierer O, Goder M, Newman H, Barak S, Barak A, et al. The prevalence of retinal and optical coherence tomography findings in preeclamptic women. Retina 2014;34:1376-83.  Back to cited text no. 20
    21.Lin P, Hahn P, Fekrat S. Peripheral retinal vascular leakage demonstrated by ultra-widefield fluorescein angiography in preeclampsia with HELLP syndrome. Retina 2012;32:1689-90.  Back to cited text no. 21
    22.Ataş M, Açmaz G, Aksoy H, Demircan S, Ataş F, Gülhan A, et al. Evaluation of the macula, retinal nerve fiber layer and choroid in preeclampsia, healthy pregnant and healthy non-pregnant women using spectral-domain optical coherence tomography. Hypertens Pregnancy 2014;33:299-310.  Back to cited text no. 22
    23.Kara N, Sayin N, Pirhan D, Vural AD, Araz-Ersan HB, Tekirdag AI, et al. Evaluation of subfoveal choroidal thickness in pregnant women using enhanced depth imaging optical coherence tomography. Curr Eye Res 2014;39:642-7.  Back to cited text no. 23
    24.Rothwell RT, Meira DM, Oliveira MA, Ribeiro LF, Fonseca SL. Evaluation of choroidal thickness and volume during the third trimester of pregnancy using enhanced depth imaging optical coherence tomography: A pilot study. J Clin Diagn Res 2015;9:NC08-11.  Back to cited text no. 24
    25.Sayin N, Kara N, Pirhan D, Vural A, Araz Ersan HB, Tekirdag AI, et al. Subfoveal choroidal thickness in preeclampsia: Comparison with normal pregnant and nonpregnant women. Semin Ophthalmol 2014;29:11-7.  Back to cited text no. 25
    26.Benfica CZ, Zanella T, Farias LB, Oppermann ML, Canani LH, Lavinsky D. Comparative analysis of choroidal thickness in third trimester pregnant women. Int J Retina Vitreous 2018;4:6.  Back to cited text no. 26
    27.Kim JW, Park MH, Kim YJ, Kim YT. Comparison of subfoveal choroidal thickness in healthy pregnancy and pre-eclampsia. Eye (Lond) 2016;30:349-54.  Back to cited text no. 27
    28.Su L, Taweebanjongsin W, Gaw SL, Rabina G, Sadda SR, Tsui I. Evaluation of the choroid in women with uncomplicated pregnancy. Transl Vis Sci Technol 2020;9:24.  Back to cited text no. 28
    29.Takahashi J, Kado M, Mizumoto K, Igarashi S, Kojo T. Choroidal thickness in pregnant women measured by enhanced depth imaging optical coherence tomography. Jpn J Ophthalmol 2013;57:435-9.  Back to cited text no. 29
    30.Jiang MS, Xu XL, Yang T, Li F, Zhang XD. Comparison of choroidal thickness in preeclamptic, healthy pregnant, and nonpregnant women: A systematic review and meta-analysis. Ophthalmic Res 2019;62:1-10.  Back to cited text no. 30
    31.Ikuno Y, Kawaguchi K, Nouchi T, Yasuno Y. Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci 2010;51:2173-6.  Back to cited text no. 31
    32.Nishida Y, Fujiwara T, Imamura Y, Lima LH, Kurosaka D, Spaide RF. Choroidal thickness and visual acuity in highly myopic eyes. Retina 2012;32:1229-36.  Back to cited text no. 32
    33.Roskal-Wałek J, Laudańska-Olszewska I, Biskup M, Gierada M, Odrobina D. Choroidal thickness in women with uncomplicated pregnancy: Literature review. Biomed Res Int 2017;2017:5694235.  Back to cited text no. 33
    34.Ulusoy DM, Duru N, Ataş M, Altınkaynak H, Duru Z, Açmaz G. Measurement of choroidal thickness and macular thickness during and after pregnancy. Int J Ophthalmol 2015;8:321-5.  Back to cited text no. 34
    35.Goktas S, Basaran A, Sakarya Y, Ozcimen M, Kucukaydin Z, Sakarya R, et al. Measurement of choroid thickness in pregnant women using enhanced depth imaging optical coherence tomography. Arq Bras Oftalmol 2014;77:148-51.  Back to cited text no. 35
    36.Dadaci Z, Alptekin H, Oncel Acir N, Borazan M. Changes in choroidal thickness during pregnancy detected by enhanced depth imaging optical coherence tomography. Br J Ophthalmol 2015;99:1255-9.  Back to cited text no. 36
    37.Dahle LO, Andersson RG, Berg G, Hurtig M, Rydén G. Alpha-adrenergic receptors in human myometrium: Changes during pregnancy. Gynecol Obstet Invest 1993;36:75-80.  Back to cited text no. 37
    38.Duvekot JJ, Peeters LL. Maternal cardiovascular hemodynamic adaptation to pregnancy. Obstet Gynecol Surv 1994;49:S1-14.  Back to cited text no. 38
    39.Demir M, Oba E, Can E, Odabasi M, Tiryaki S, Ozdal E, et al. Foveal and parafoveal retinal thickness in healthy pregnant women in their last trimester. Clin Ophthalmol 2011;5:1397-400.  Back to cited text no. 39
    40.Benfica CZ, Zanella T, Farias LB, Oppermann ML, Canani LH, Lavinsky D. Choroidal thickness in preeclampsia measured by spectral-domain optical coherence tomography. Int Ophthalmol 2019;39:2069-76.  Back to cited text no. 40
    41.Sharudin SN, Saaid R, Samsudin A, Mohamad NF. Subfoveal choroidal thickness in pre-eclampsia. Optom Vis Sci 2020;97:81-5.  Back to cited text no. 41
    42.Taradaj K, Ginda T, Maciejewicz P, Suchonska B, Wielgos M, Kecik D, et al. Does pregnancy influence eye parameters? Assessment of choroidal thickness using EDI-OCT before and after labour depending on the way of delivery method. Ginekol Pol 2020;91:668-73.  Back to cited text no. 42
    43.Takahashi J, Kado M, Mizumoto K, Igarashi S, Kojo T. Changes in subfoveal choroidal thickness during pregnancy and after delivery. Ophthalmic Surg Lasers Imaging Retina 2017;48:816-21.  Back to cited text no. 43
    44.Wexler A, Sand T, Elsås TB. Macular thickness measurements in healthy Norwegian volunteers: An optical coherence tomography study. BMC Ophthalmol 2010;10:13.  Back to cited text no. 44
    
  [Figure 1]
 
 
  [Table 1], [Table 2], [Table 3], [Table 4]
  Top  

留言 (0)

沒有登入
gif